TRV
42
5
AMG
57
-3
ESS
33
2
ADP
39
3
BLK
49
3
BMY
66
-3
SIG
67
-5
NOV
55
-3
COF
47
-3
XYL
33
-2
FSLR
49
-3
IBM
67
3
YUM
58
2
DD
41
-3
A
37
3
AES
46
2
SJM
19
2
KMB
42
-2
FLR
30
-2
EOG
62
6
TRV
42
5
AMG
57
-3
ESS
33
2
ADP
39
3
BLK
49
3
BMY
66
-3
SIG
67
-5
NOV
55
-3
COF
47
-3
XYL
33
-2
FSLR
49
-3
IBM
67
3
YUM
58
2
DD
41
-3
A
37
3
AES
46
2
SJM
19
2
KMB
42
-2
FLR
30
-2
EOG
62
6
Financhill
Back

Bank First Corp. Vs. BridgeBio Pharma, Inc. Industry Stock Comparison

Sell
50

BFC
Bank First Corp.

Last Price:
$136.73
Seasonality Move:
8.32%
Buy
51

BBIO
BridgeBio Pharma, Inc.

Last Price:
$73.17
Seasonality Move:
5.25%
Sell
50
Bank First Corp. (BFC) is a Sell

Is Bank First Corp. a Buy, Sell or Hold?

  • The current Bank First Corp. [BFC] share price is $136.99. The Score for BFC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BFC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
BridgeBio Pharma, Inc. (BBIO) is a Buy

Is BridgeBio Pharma, Inc. a Buy, Sell or Hold?

  • The current BridgeBio Pharma, Inc. [BBIO] share price is $73.15. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BFC Stock Price Chart

What is Bank First Corp.'s stock price today?

  • The Bank First Corp. share price today is $136.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BFC is experiencing buying pressure, which is a positive indicator for future bullish movement.

BBIO Stock Price Chart

What is BridgeBio Pharma, Inc.'s stock price today?

  • The BridgeBio Pharma, Inc. share price today is $73.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.

BFC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 53.79 Buy
Chaikin Money Flow: 23083 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (132.79 - 137.09) Buy
Bollinger Bands (100): (125.23 - 141.01) Buy

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 55.21 Buy
Chaikin Money Flow: -128497 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.58 - 72.4) Buy
Bollinger Bands (100): (67.73 - 76.59) Buy

BFC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 134.06 Buy
20-day SMA: 134.35 Buy
50-day SMA: 139.1 Sell
200-day SMA: 128.67 Buy
8-day EMA: 134.73 Buy
20-day EMA: 135.06 Buy
50-day EMA: 135.7 Buy
200-day EMA: 127.83 Buy

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.71 Buy
20-day SMA: 70.4 Buy
50-day SMA: 71.53 Buy
200-day SMA: 61.39 Buy
8-day EMA: 72.08 Buy
20-day EMA: 70.93 Buy
50-day EMA: 70.94 Buy
200-day EMA: 62.01 Buy

Bank First Corp. Earnings Growth & BFC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.92 per share, a decrease next quarter of $0.10 per share, an increase this year of $3.10 per share, and an increase next year of $0.48 per share.

BridgeBio Pharma, Inc. Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.26 per share, an increase this year of $1.05 per share, and an increase next year of $2.15 per share.

Bank First Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BridgeBio Pharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):